Education
About Us
Working with TipRanks
Follow Us
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (HK:8189)
:8189
RESEARCH TOOLSreports
8189 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.65
Previous CloseN/A
Volume305.00K
Average Volume (3M)1.89M
Market Cap
HK$1.05B
Enterprise ValueHK$1.02B
Total Cash (Recent Filing)HK$92.73M
Total Debt (Recent Filing)¥110.53M
Price to Earnings (P/E)―
Beta-0.02
Next Earnings
Aug 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,436,400,000
10 Day Avg. Volume2,174,900
30 Day Avg. Volume1,887,800
Financial Highlights & Ratios
PEG Ratio-5.70
Price to Book (P/B)35.55
Price to Sales (P/S)0.00
P/FCF Ratio121.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8189 FAQ
What was Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price range in the past 12 months?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H lowest stock price was HK$0.07 and its highest was HK$0.65 in the past 12 months.
What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s market cap?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s market cap is HK$1.05B.
When is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s upcoming earnings report date is Aug 12, 2025 which is in 17 days.
How were Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s earnings last quarter?
Currently, no data Available
Is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H overvalued?
According to Wall Street analysts Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price is currently Overvalued.
Does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H pay dividends?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H does not currently pay dividends.
What is Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tianjin TEDA Biomedical Engineering Co. Ltd. Class H have?
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H has 1,436,400,000 shares outstanding.
What happened to Tianjin TEDA Biomedical Engineering Co. Ltd. Class H’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Tianjin TEDA Biomedical Engineering Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:8189
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
486.41%
12-Months-Change
Fundamentals
Return on Equity
-81.86%
Trailing 12-Months
Asset Growth
5.98%
Trailing 12-Months
Company Description
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H
Tianjin TEDA Biomedical Engineering Co. Ltd. Class H (8189) is a China-based company primarily engaged in the development, production, and sale of biomedical products. The company operates in the healthcare sector, focusing on the research and commercialization of innovative medical technologies and solutions. Its core products include diagnostic reagents, medical testing equipment, and other biomedical devices designed to improve healthcare outcomes.
Technical Analysis
China BlueChemical
―
China XLX Fertiliser Ltd.
―
Ko Yo Chemical (Group) Limited
―
Sinofert Holdings
―